| NUREXONE BIOLOGIC INC. |
| Kanada |
| Gesundheit |
| CA67059R1091 / A3DNSU |
| J90 (Frankfurt) |
| FRA:J90, ETR:J90, J90:GR |
| - |
| https://nurexone.com/ |
|
NurExone Biologic Inc. is a biopharmaceutical company specializing in the development of exosome-based therapies for regenerative medicine, with a primary focus on treating central nervous system injuries such as spinal cord and traumatic brain injur..
>Volltext.. |
| 22.62 Mio. EUR |
| 21.33 Mio. EUR |
| - |
| -5.3 Mio. EUR |
| -5.55 Mio. EUR |
| -0.07 EUR |
| 0.06 Mio. EUR |
| 1.35 Mio. EUR |
| -4.09 Mio. EUR |
| 2.03 |
| - |
| -7.11% |
| - |
| - |
| - |
| - |
| NUREXONE |
| 01.09.26 |
|
||||
|